The biomarker phase is witnessing swift technological breakthroughs and high desire for individualized medicine. Consequently, to make sure individual entry to these new technologies, a reimbursement framework should be labored upon to fulfill the altering market scenario. Array and proteomics technologies advancements have addressed the problems of identifying and knowledge https://lemmyj284aob6.blogvivi.com/profile